267 related articles for article (PubMed ID: 24762683)
21. Tetracycline- and furazolidone-containing quadruple regimen as rescue treatment for Helicobacter pylori infection: a single center retrospective study.
Zhang Y; Gao W; Cheng H; Zhang X; Hu F
Helicobacter; 2014 Oct; 19(5):382-6. PubMed ID: 24849129
[TBL] [Abstract][Full Text] [Related]
22. Moxifloxacin-containing triple therapy after non-bismuth quadruple therapy failure for Helicobacter pylori infection.
Lim JH; Lee DH; Lee ST; Kim N; Park YS; Shin CM; Song IS
World J Gastroenterol; 2015 Dec; 21(46):13124-31. PubMed ID: 26673999
[TBL] [Abstract][Full Text] [Related]
23. Fourteen- vs seven-day bismuth-based quadruple therapy for second-line Helicobacter pylori eradication.
Hwang JJ; Lee DH; Lee AR; Yoon H; Shin CM; Park YS; Kim N
World J Gastroenterol; 2015 Jul; 21(26):8132-9. PubMed ID: 26185386
[TBL] [Abstract][Full Text] [Related]
24. A comparison between sequential therapy and a modified bismuth-based quadruple therapy for Helicobacter pylori eradication in Iran: a randomized clinical trial.
Fakheri H; Taghvaei T; Hosseini V; Bari Z
Helicobacter; 2012 Feb; 17(1):43-8. PubMed ID: 22221615
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of bismuth quadruple regimens containing tetracycline or furazolidone for initial eradication of Helicobacter pylori.
Wang J; Cao Y; He W; Li X
Medicine (Baltimore); 2021 Dec; 100(51):e28323. PubMed ID: 34941132
[TBL] [Abstract][Full Text] [Related]
26. [Five-day rabeprazole-based triple therapy for helicobacter pylori infection].
Wang F; Wang XY; Jia Y; Shen SR; Xu CX; Tang WL; Liu SJ; Chen X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Oct; 29(5):589-91. PubMed ID: 16137055
[TBL] [Abstract][Full Text] [Related]
27. Comparison of Helicobacter pylori Eradication Rates of 2-Week Levofloxacin-Containing Triple Therapy, Levofloxacin-Containing Bismuth Quadruple Therapy, and Standard Bismuth Quadruple Therapy as a First-Line Regimen.
Kahramanoğlu Aksoy E; Pirinçci Sapmaz F; Göktaş Z; Uzman M; Nazlıgül Y
Med Princ Pract; 2017; 26(6):523-529. PubMed ID: 29131124
[TBL] [Abstract][Full Text] [Related]
28. The efficacy of furazolidone-based quadruple therapy for eradication of Helicobacter pylori infection in Iranian patients resistant to metronidazole-based quadruple therapy.
Ebrahimi-Dariani N; Mirmomen S; Mansour-Ghanaei F; Noormohammadpoor P; Sotodehmanesh R; Haghpanah B; Bahrami H
Med Sci Monit; 2003 Aug; 9(8):PI105-8. PubMed ID: 12942042
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of 14-d vs 7-d moxifloxacin-based triple regimens for second-line Helicobacter pylori eradication.
Hwang JJ; Lee DH; Lee AR; Yoon H; Shin CM; Park YS; Kim N
World J Gastroenterol; 2015 May; 21(18):5568-74. PubMed ID: 25987781
[TBL] [Abstract][Full Text] [Related]
30. Helicobacter pylori eradication in childhood after failure of initial treatment: advantage of quadruple therapy with nifuratel to furazolidone.
Nijevitch AA; Shcherbakov PL; Sataev VU; Khasanov RSh; Al Khashash R; Tuygunov MM
Aliment Pharmacol Ther; 2005 Nov; 22(9):881-7. PubMed ID: 16225499
[TBL] [Abstract][Full Text] [Related]
31. Outcomes of furazolidone- and amoxicillin-based quadruple therapy for
Zhang YW; Hu WL; Cai Y; Zheng WF; Du Q; Kim JJ; Kao JY; Dai N; Si JM
World J Gastroenterol; 2018 Oct; 24(40):4596-4605. PubMed ID: 30386109
[TBL] [Abstract][Full Text] [Related]
32. [Effect of birid triple viable on peptic ulcer patients with Helicobacter pylori infection].
Xu C; Xiao L; Zou H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Sep; 35(9):1000-4. PubMed ID: 20871168
[TBL] [Abstract][Full Text] [Related]
33. Low-dose furazolidone in triple and quadruple regimens for Helicobacter pylori eradication.
Fakheri H; Merat S; Hosseini V; Malekzadeh R
Aliment Pharmacol Ther; 2004 Jan; 19(1):89-93. PubMed ID: 14687170
[TBL] [Abstract][Full Text] [Related]
34. Comparison of Helicobacter pylori eradication rates of standard 14-day quadruple treatment and novel modified 10-day, 12-day and 14-day sequential treatments.
Sapmaz F; Kalkan IH; Güliter S; Atasoy P
Eur J Intern Med; 2014 Mar; 25(3):224-9. PubMed ID: 24268371
[TBL] [Abstract][Full Text] [Related]
35. Doxycycline-based quadruple regimen versus routine quadruple regimen for rescue eradication of Helicobacter pylori: an open-label control study in Chinese patients.
Wang Z; Wu S
Singapore Med J; 2012 Apr; 53(4):273-6. PubMed ID: 22511052
[TBL] [Abstract][Full Text] [Related]
36. Randomised clinical trial: a comparative study of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori infection in naïve patients.
Park HG; Jung MK; Jung JT; Kwon JG; Kim EY; Seo HE; Lee JH; Yang CH; Kim ES; Cho KB; Park KS; Lee SH; Kim KO; Jeon SW
Aliment Pharmacol Ther; 2012 Jan; 35(1):56-65. PubMed ID: 22066530
[TBL] [Abstract][Full Text] [Related]
37. Second-line levofloxacin-based triple schemes for Helicobacter pylori eradication.
Di Caro S; Franceschi F; Mariani A; Thompson F; Raimondo D; Masci E; Testoni A; La Rocca E; Gasbarrini A
Dig Liver Dis; 2009 Jul; 41(7):480-5. PubMed ID: 18974025
[TBL] [Abstract][Full Text] [Related]
38. Quadruple therapy with lactoferrin for Helicobacter pylori eradication: a randomised, multicentre study.
Zullo A; De Francesco V; Scaccianoce G; Hassan C; Panarese A; Piglionica D; Panella C; Morini S; Ierardi E
Dig Liver Dis; 2005 Jul; 37(7):496-500. PubMed ID: 15975536
[TBL] [Abstract][Full Text] [Related]
39. Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia.
Uygun A; Kadayifci A; Yesilova Z; Safali M; Ilgan S; Karaeren N
Clin Ther; 2008 Mar; 30(3):528-34. PubMed ID: 18405790
[TBL] [Abstract][Full Text] [Related]
40. [Efficacy of 4 kinds of triple strategy for Helicobacter pylori eradication].
Li Y; Wang XY; Shen SR
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Dec; 33(12):1129-31. PubMed ID: 19141980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]